It may be about the underlying patents, but it's also about the fact that REVO directors are using Eyetalk365 to avoid sharing proceeds from those patents with REVO shareholders.
REVO directors are not reporting to REVO shareholders. REVO directors are working with Eyetalk365. The patents must have generated some income from court settlements. BUT: neither REVO directors nor Eyetalk365 are reporting any income to REVO shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.